Pentamidine
56 interactions 4 explained in plain English
Also sold as:
NebuPent
Pentam
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 4, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Moxifloxacin
Ketoconazole Topical
Octreotide
Inotuzumab Ozogamicin Injection
Histrelin Implant
Oxaliplatin Injection
Major
Pentamidine Amitriptyline Elavil Explained An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Sertraline Explained An increased risk of QT interval prolongation Details Pentamidine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Pentamidine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Pentamidine Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Pentamidine Arsenic Trioxide Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Pentamidine Arsenic Trioxide Injection Trisenox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Pentamidine Azithromycin AzaSite Increased risk of QT interval prolongation Details Pentamidine Anagrelide Agrylin Increased risk of QT interval prolongation Details Pentamidine Bedaquiline Sirturo Increased risk of QT interval prolongation Details Pentamidine Chloroquine Aralen® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Cidofovir Injection Vistide® Nephrotoxicity Details Pentamidine Dasatinib Phyrago An increased risk of QT interval prolongation Details Pentamidine Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Pentamidine Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Pentamidine Disopyramide Norpace An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Dofetilide Tikosyn An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Dolasetron Anzemet An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Dolasetron Injection Anzemet An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Encorafenib Braftovi Increased risk of QT interval prolongation Details Pentamidine Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Pentamidine Flecainide Tambocor® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Foscarnet Injection Foscavir Symptomatic and severe hypocalcemia and nephrotoxicity Details Pentamidine Fostemsavir Rukobia Increased risk of torsade de pointes Details Pentamidine Gemifloxacin Factive An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Glasdegib Daurismo Increased risk of QT interval prolongation Details Pentamidine Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Pentamidine Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Pentamidine Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Pentamidine Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Pentamidine Isradipine DynaCirc® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Pentamidine Ivabradine Corlanor Increased risk of QT prolongation Details Pentamidine Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Pentamidine Lefamulin Xenleta Increased risk of QT interval prolongation Details Pentamidine Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Pentamidine Levofloxacin Levaquin Increased risk of QT interval prolongation Details Pentamidine Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Pentamidine Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.